Birchview Capital, LP NBIX Holdings History
Birchview Capital, LP's Neurocrine Biosciences Inc Holding Summary
As of 2025-03-31, Birchview Capital, LP held 30,240.00 shares of Neurocrine Biosciences Inc(NBIX), totaling $3.34 Mil. This investment constitutes 2.9% of their stock portfolio, and Birchview Capital, LP now holds 0.03% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2015Q3. And since then Birchview Capital, LP has made 9 purchases of NBIX, at an average price of $92.65, for a total of 161,480.00 shares. In addition, there have been 7 sales at an average price of $132.84 for 131,240.00 shares. Based on historical transaction data and NBIX's current price of $127.88, Birchview Capital, LP's estimated gain on his NBIX holdings is $6.34 Mil, reflecting a 42.37% gain to date.
Birchview Capital, LP NBIX ($127.88) Holding Chart
Birchview Capital, LP NBIX ($127.88) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
